Tải bản đầy đủ (.pdf) (3 trang)

Andersons pediatric cardiology 2353

Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (84.48 KB, 3 trang )

bradycardiaandpacing,1325,1325f–1326f
catheterablation,roleof,1328–1329
implantablecardioverter-defibrillators,1325–1326
intraatrialreentranttachycardias,1327–1328
associatedliverdisease,1331–1334,1331f
clinicalimplications,1335
futuredirections,1335–1336
lymphaticinsufficiency,1332,1333f
neurocognitiveoutcomes,1335
peripheralvasculardisease,1334
plasticbronchitis,1332–1333,1333f–1334f,1333t
protein-losingenteropathy,1333–1334
psychologicalhealth,1335
qualityoflife,1335
cardiaccatheterizationandtranscatheterinterventionin,1340–1342
aortopulmonarycollateralembolization,1342
fenestrationclosure,1340–1342,1341f
venovenouscollaterals,1341,1342f
consequencesof,1320–1321
failureof,1342–1348
anticoagulation,1345–1346
definitionsof,1342–1343,1343t
exercisefor,1345
hearttransplantation,timingof,1347–1348
phenotypicclassification,1343–1345,1343t
surgicalmanagement,1346–1347,1346f–1347f
hematologicandimmunologiccomplicationsof,1329–1331,1329f
immunologicabnormalities,1330–1331
renaldysfunction,1331
thromboembolism,riskfactorsfor,1330,1330f
impairedexercisecapacityin,1321–1324,1321f–1323f


chronotropicincompetence,1322
impairedsomaticgrowth,1323–1324
preloadinsufficiency,1321–1322
restrictivelungdisease,1322–1323
lateoutcomewith,1317–1320,1319f
preoperativefactorsfor,1318–1319,1320t
riskfactorsforlatemortality,1318
procedurefor,evolutionof,1317,1318f–1319f
“well,”managementof,1336–1340
aldosteroneantagonistsin,1338–1339
angiotensin-convertingenzymeinhibitionin,1338–1339
birthcontrolfor,1339–1340,1339t
β-blockadein,1338–1339
exercisefor,1339


medicaltreatmentfor,1337–1338
practiceguidelines,roleof,1336–1337,1337f

“Fontanfailure,”,1243
Fontanpathway,1243–1244,1244f,1273–1306,1274b
futureconsiderationsin,1305–1306
modifiedFontanprocedure,1300–1304,1300b
decisionmakingin,1301–1303
postoperativeconsiderationsin,1303–1304,1303b
preoperativeevaluationin,1300,1300t
surgicalstrategiesin,1300–1301,1301f–1302f

neonatalstabilizationin,1273–1296
outcomesalong,1304–1305

postoperativemanagementin,1285–1296,1285b
acutedecompensation,1292–1293
acutedeterioration,cardiacarrest,andmechanicalcirculatorysupport,1293–1294
acuterespiratoryfailureafterextubation,1294–1295
bedsidepreparedness,1285,1285t
bleeding,1289–1290
centralnervoussystemevaluationandmonitoring,1290–1291,1291t
delayedsternalclosure,1290
deviationsin,1292,1293f
failuretoprogress,1295,1295b
familysupportanddischarge,1295–1296
feedingandnutrition,1291–1292
invasiveandnoninvasivemonitoringandsurveillance,1285–1289,1286t–1288t
mechanicalventilation,1290
pain,sedation,andneurodevelopmentalcare,1291,1292t
spontaneousventilation,1290
systemicoxygendeliveryassessment,1290

preoperativemanagementin,1273–1278,1274b
feedingandnutritionalchallenges,1278
monitoringandvascularaccess,1273–1275,1274t
nursingconsiderationandfamilysupport,1277–1278
physiologyandpresentationofshock,1275–1276
systemicoxygendeliveryassessment,1276–1277,1276t

superiorcavopulmonaryconnection,1296–1300,1296b
decisionmakingin,1297–1298
postoperativeconsiderationsin,1298–1300,1298b
preoperativeevaluationof,1296,1296t
surgicalstrategiesfor,1296–1297,1296f–1297f


surgicaloptionsin,1278–1285


leavingoperatingroom,1284–1285
restrictedorduct-dependentpulmonarybloodflow,1278–1280,1278f–1279f
restrictedorduct-dependentsystemicbloodflow,1280–1284,1281f–1283f
unobstructedsystemicandpulmonarybloodflow,1280,1280f

surgicalstrategiesin,1273–1296

Fontanphysiology,1377–1378
indiagnosticcatheterization,251
exercisetestingand,400

Fontanpressures,normal,Fontanfailurewith,1344–1345
Fontanprocedure,1243
infunctionallyuniventricularheart,1268

Forearmresistancevessels,endothelialfunctionin,1367
Foreignbodies,removalof,inpulmonaryvenousstenosis,interventional
techniquesfor,274–275
4Dechocardiography,perfusionestimationusing,100f,101
Four-chambercine,320t–321t
Four-dimensional(or7D)flow,ofcardiacmagneticresonance,323
Frequency,ofultrasound,281
Friedreichataxia
cardiacinvolvementin,1105–1106
hypertrophiccardiomyopathyand,1148–1149


Fucosidosis,cardiacinvolvementin,1092
Functionalcardiacabnormalities,449–450
arrhythmias,449–450
myocardialfibrosisandmyocardialinfarction,450

Functionallyuniventricularcirculation,cardiopulmonaryinteractionsin,1183
Functionallyuniventricularheart(fUVH),1273
anatomicconsiderationsin,1245–1259
atrioventricularvalvaratresiain,1250–1253,1251f–1252f
complexdouble-outletventriclein,1257–1258
double-inletventriclein,1253–1254,1253f–1254f
hypoplasticleftheartsyndromein,1248–1249,1248f–1250f



×